StonvexLoading…
StonvexStonvexStonvexCore line items from AVX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.51M | $2.34M | $1.25M | $725.21K |
Operating Income | $-44.57M | $-21.67M | $-5.96M | $-3.18M |
Net Income | $-46.39M | $-33.20M | $-16.56M | $-8.21M |
EPS (Diluted) | $-0.48 | $-2.15 | $-24.85 | $-31.59 |
Total Assets | $157.09M | $194.96M | $16.51M | $15.24M |
Total Liabilities | $14.30M | $7.99M | $4.36M | $11.18M |
Cash & Equivalents | $16.47M | $22.14M | $894.70K | $185.31K |
Free Cash Flow OCF − CapEx | $-3.87M | $-15.69M | $-6.51M | $-4.08M |
Shares Outstanding | 89.80M | 92.94M | 4.13M | 420.90K |